저자의 연구 키워드

저자의 연구 키워드

#36-Item Short-Form Health Survey

#노인

#예방적 난소절제술

#예방적 유방절제술

#유방암

#임상 데이터 웨어하우스

#항암요법

#Adaptive design

#Adjuvant chemotherapy

#Advanced solid cancer

#Adverse events

#Aged

#Albumin-bound paclitaxel

#Alectinib

#ALK fusion

#Anemia

#Angiogenesis

#Anthracycline

#Anticancer drugs

#Anti-cancer therapy

#Antineoplastic Agents

#Antitumor

#Asia

#Biliary tract neoplasms

#Biological markers

#Biomarkers

#BMX

#Body Mass Index

#Brain metastasis

#BRCA1 돌연변이

#Breast cancer

#Breast neoplasm

#Breast Neoplasms

#CA 19-9 antigen

#Carbonic anhydrase 12

#Carbonic anhydrase 9

#Carcinoembryonic antigen

#Chemoradiotherapy

#Chemotherapy

#Circulating tumor DNA

#Cisplatin

#CKD-516

#Classification Criteria

#Clinical trial

#Clonal evolution

#Colorectal neoplasms

#Colorectal surgery

#Computerized medical records systems

#Desensitization

#Direct oral anticoagulants

#Drug approval

#Drug Screening Assays

#Drug therapy

#Efficacy

#Elderly

#Epidermal growth factor receptor-neu receptor

#Epirubicin

#Eribulin

#Ethics Committees

#Fluorescence

#Fulvestrant

#Gastrointestinal stromal tumors

#Gemcitabine

#Genomic alterations

#Gout

#Health-Related Quality of Life

#Hemorrhage

#Hepatocellular carcinoma

#HER2

#High-Throughput Nucleotide Sequencing

#HM781-36B

#Hypersensitivity

#Immune checkpoint inhibitors

#In Situ Hybridization

#Incidence

#Independent central review committees

#Inflammatory myofibroblastic tumor

#Infrastructure

#Iron Deficiency

#Ki-67 antigen

#Korea

#Korean

#KX-01

#Lung neoplasms

#Lymph nodes

#Mastectomy

#Metastasis

#Microtubules

#Mitotic catastrophe

#Molecular tumor board

#Monosodium Urate

#Myeloproliferative neoplasms

#National Institutes of Health (U.S.)

#Neoadjuvant therapy

#Neoplasm metastasis

#Neoplasms

#Next-generation sequencing

#Nutritional support

#Obesity

#Overall survival

#Oxaliplatin

#Paclitaxel

#Palbociclib

#Palliative care

#Pancreatic neoplasms

#Pattern of care study

#PD-L1

#Pharmacology

#Phase I clinical trial

#Phase II trial

#Phase IV clinical trial

#Platinum

#Precision medicine

#Primary systemic therapy

#Prognosis

#Progression-free survival

#Radiotherapy

#Recurrence

#S-1

#Safety

#Sensitivity

#Sensitivity and Specificity

#Sentinel lymph node biopsy

#Sentinel lymph node metastases

#Sex

#Sex characteristics

#Sex disparity

#Solid tumor

#Specificity

#Src kinase inhibitor

#Stomach neoplasm

#Stomach neoplasms

#Stromal cells

#Survival

#Taxane

#Terminal cancer patients

#Therapeutic Use

#Thrombosis

#TP53 mutation

#Trastuzumab

#Triple negative breast neoplasms

#TSU-68

#Tumor biomarker

#Vascular disrupting agent

#Venous thromboembolism

#Vinorelbine